abstract |
The present invention relates to compounds of formula (I), stereoisomers, enantiomers, pharmaceutically acceptable salts or amino acid conjugates thereof; in formula (I), each variable is as defined herein. The invention also relates to pharmaceutical compositions thereof, which are useful as modulators of farnesoid X receptor (FXR) activity. |